Watch Ticker

PUMA BIOTECHNOLOGY INC

Go to PUMA BIOTECHNOLOGY INC Website

$4.75

(%)

Live

Previous Close

$4.75

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$229.1 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat

Puma Biotechnology (PBYI) reports narrower-than-expected first-quarter 2024 loss. The company maintains its revenue guidance for 2024.

Related tickers: LGND, PBYI, ANIP, VYGR.

Read Full Article

Zacks Equity Research - Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates

Puma Biotech (PBYI) delivered earnings and revenue surprises of 68.75% and 5.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: PBYI, CLNN.

Read Full Article

Trending Tickers

CRIS

XNAS

$16.20

(%)

CVNA

XNYS

$116.66

(%)

LASE

XNAS

$2.13

(%)

SQ

XNYS

$71.60

(%)

MLGO

XNAS

$2.44

(%)